Economic Insights and Deficits in European Biotechnology Patent Policy

Gilroy, Bernard Michael and Vollpert, Tobias (2002): Economic Insights and Deficits in European Biotechnology Patent Policy. Unpublished.

Abstract

The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that the DBP has two major flaws from the economist's point of view, under which particularly small and medium-sized enterprises, the driving force of this young line of business, suffer.

• Item Type: MPRA Paper
• Language: English
• Keywords: Patent policy; biotechnology sector; Europe
• Subjects: L - Industrial Organization > L6 - Industry Studies: Manufacturing > L65 - Chemicals; Rubber; Drugs; Biotechnology

References

Bio Technologie — Das Jahr- und Adreßbuch 2001, Vol. 15, Berlin 2000, Biocom-Verlag.

Chang, H.F.: Patent scope, antitrust policy, and cumulative innovation, in: The RAND Journal of Economics, Vol. 26, No. 1, 1995, pp. 34–57.

Denicolo, V.: The optimal life of a patent when the timing of innovation is stochastic, in: International Journal of Industrial Organization, Vol. 17, No. 6, 1999, pp. 827–846.

Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, L 213, Vol. 41, 1998, pp. 13–21.

Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, Article 3, para. 2.

Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of b biotechnological inventions, in: Official Journal of the European Communities Article 2, para. 1 (a).

Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, Article 3, para. 1.

Dunn, M.H.: Wachstum und endogener technologischer Wandel, in: ORDO, Jahrbuch für die Ordnung von Wirtschaft und Gesellschaft, Vol. 51, 2000, pp. 277–299.

Eger, T., Weise, P.: Innovation, Imitation und Patentrecht im Systemvergleich, in: H. E. Gramatzki, F. Klinger, H. G. Nutzinger (eds.): Wissenschaft, Technik und Arbeit: Innovationen in Ost und West, Kassel 1990, VWL-inform, pp. 107–133.

Europäisches Patentamt (ed.): Nutzung des Patentschutzes in Europa: Repräsentative Erhebung erstellt im Auftrag des Europäischen Patentamts; Schriftenreihe des Europäischen Patentamtes, Vol. 3, Munich 1994.

Gilbert, R., Shapiro, C.: Optimal patent length and breadth, in: The RAND Journal of Economics, Vol. 21, No. 1, 1990, pp. 106–112.

Karl, H.D., Scholz, L., Wiesner, G.: Biotechnologie—Abbau von Investitionshemmnissen im staatlichen Einflußbereich, in: ifo Schnelldienst, Vol. 42, No. 22, 1989, pp. 9–20.

Kienle, T.: Die neue EU-Richtlinie zum Schutz biotechnologischer Erfindungen—Rechtliche und ethische Probleme der Patentierung biologischer Substanzen, in: Europäisches Wirtschafts- & Steuerrecht, Vol. 9, No. 5, 1998, pp. 156–162

Kiper, M.: Trendwende in der Gentechnik: Fiktion oder Realität? Zu den wirtschaftlichen und gesellschaftlichen Perspektiven der Genund Biotechnologie, in: WSI Mitteilungen, Vol. 51, No. 2, 1998, pp. 115–122.

Klemperer, P.: How broad should the scope of patent protection be?, in: The RAND Journal of Economics, Vol. 21, No. 1, 1990, pp. 113–130.

Lerner, J.: The importance of patent scope: an empirical analysis, in: RAND Journal of Economics, Vol. 25, No. 2, 1994, pp. 319–333.

Luttermann, C.: Patentschutz für Biotechnologie. Die europäische Richtlinie über den rechtlichen Schutz biotechnologischer Erfindungen, in: Recht der internationalen Wirtschaft, Vol. 44, No. 12, 1998, pp. 916–920.

Matutes, C., Regibeau, P., Rockett, K.: Optimal patent design and the diffusion of innovations, in: The RAND Journal of Economics, Vol. 27, No. 1, 1996, pp. 60–83.

Plimier, M.: Genetech, Inc. v. Novo Nordisk & University of California v. Eli Lilly And Co., in: Berkeley Technology Law Journal, Vol. 13, No. 1, 1998, pp. 149–161.

Vita, G.: Wachstumsindustrie Gen- und Biotechnologie, Life Sciences als internationale Zukunftschance, in: Internationale Politik, Vol. 53, No. 8, 1998, pp. 7–14.

Waterson, M.: The Economics of Product Patents, in: The American Economic Review, Vol. 80, No. 4, 1990, pp. 860–869;

G. Llobet: Patent Design under the Threat of Litigation, in: Asociation Argentina De Economia Politica (ed.): The Twelfth World Congress Of The International Economic Association, Buenos Aires 1999 (CD Rom).